The effects of HER2 monoclonal antibody in women with HER2-overexpressing metastatic breast cancer

被引：0
|
作者：
Boer R.
机构：
来源：
Breast Cancer Research | / 1卷 / 1期
关键词：
HER-2; Metastatic breast cancer; Monoclonal antibody;
D O I：
10.1186/bcr-1999-66610
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
相关论文
共 50 条
  • [41] Trastuzumab induces gastrointestinal side effects in HER2-overexpressing breast cancer patients
    Noor Al-Dasooqi
    Joanne M. Bowen
    Rachel J. Gibson
    Thomas Sullivan
    Jude Lees
    Dorothy M. Keefe
    Investigational New Drugs, 2009, 27 : 173 - 178
  • [42] HER2-overexpressing breast cancer: time for the cure with less chemotherapy?
    Loi, Sherene
    de Azambuja, Evandro
    Pugliano, Lina
    Sotiriou, Christos
    Piccart, Martine J.
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (06) : 547 - 558
  • [43] Trastuzumab induces gastrointestinal side effects in HER2-overexpressing breast cancer patients
    Al-Dasooqi, Noor
    Bowen, Joanne M.
    Gibson, Rachel J.
    Sullivan, Thomas
    Lees, Jude
    Keefe, Dorothy M.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (02) : 173 - 178
  • [44] Prognostic Value of Basal Phenotype in HER2-overexpressing Breast Cancer
    Bagaria, Sanjay P.
    Ray, Partha S.
    Wang, Jinhua
    Kropcho, Luisa
    Chung, Alice
    Sim, Myung-Shin
    Shamonki, Jaime M.
    Martino, Silvana
    Cui, Xiaojiang
    Giuliano, Armando E.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (03) : 935 - 940
  • [45] Magnitude of HER2 amplification as a predictive factor for HER2-overexpressing metastatic breast cancer treated with weekly paclitaxel plus trastuzumab as first-line chemotherapy
    Han, H.
    Kim, J.
    Im, S.
    Park, J.
    Oh, S.
    Oh, D.
    Kim, J.
    Lee, K.
    Kim, T.
    Bang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] Effect of Oncoxin Oral Solution in HER2-Overexpressing Breast Cancer
    Hernandez-Garcia, Susana
    Gonzalez, Verena
    Sanz, Eduardo
    Pandiella, Atanasio
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2015, 67 (07): : 1159 - 1169
  • [47] Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
    Natoli, Clara
    Vici, Patrizia
    Sperduti, Isabella
    Grassadonia, Antonino
    Bisagni, Giancarlo
    Tinari, Nicola
    Michelotti, Andrea
    Zampa, Germano
    Gori, Stefania
    Moscetti, Luca
    De Tursi, Michele
    Panebianco, Michele
    Mauri, Maria
    Ferrarini, Ilaria
    Pizzuti, Laura
    Ficorella, Corrado
    Samaritani, Riccardo
    Mentuccia, Lucia
    Iacobelli, Stefano
    Gamucci, Teresa
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (07) : 1229 - 1240
  • [48] Therapeutic strategies and mechanisms of tumorigenesis of HER2-overexpressing breast cancer
    Emde, Anna
    Koestler, Wolfgang J.
    Yarden, Yosef
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 84 : E49 - E57
  • [49] ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
    Isabel Pinhel
    Margaret Hills
    Suzanne Drury
    Janine Salter
    Georges Sumo
    Roger A'Hern
    Judith M Bliss
    Ivana Sestak
    Jack Cuzick
    Peter Barrett-Lee
    Adrian Harris
    Mitch Dowsett
    Breast Cancer Research, 14
  • [50] ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
    Pinhel, Isabel
    Hills, Margaret
    Drury, Suzanne
    Salter, Janine
    Sumo, Georges
    A'Hern, Roger
    Bliss, Judith M.
    Sestak, Ivana
    Cuzick, Jack
    Barrett-Lee, Peter
    Harris, Adrian
    Dowsett, Mitch
    BREAST CANCER RESEARCH, 2012, 14 (02)
12345